The first patient was diagnosed with Erdheim-Chester disease (ECD) and exhibited evidence of a MAP2K1 mutation, concomitant with chronic myelomonocytic leukemia. This evidence concerns the gene MAP2K1 and chronic myelomonocytic leukemia.